by Lorenzo Monasta | Mar 29, 2024 | Infectious diseases and AMR, Italian GBD Initiative
By 2050, it is estimated that antimicrobial resistance (AMR) will cause 10 million annual deaths worldwide, costing up to $100 trillion. Antibiotic resistance (ABR) is the most significant health threat and, in 2019, caused 1.27 million deaths globally. One in 5...
by Lorenzo Monasta | Nov 6, 2023 | Infectious diseases and AMR, Italian GBD Initiative
In 2016, the World Health Assembly adopted the resolution to eliminate viral hepatitis by 2030. A GBD study led by the University of Milan-Bicocca, published in the journal The Lancet Public Health, aimed to provide an overview of the impact of hepatitis B virus (HBV)...
by admin | Nov 29, 2022 | Infectious diseases and AMR
On November 21, 2022, a recent IHME paper was published in The Lancet to present the results of an analysis of the burden of antimicrobial resistance (AMR) and bacterial pathogens and its impact on health globally. The work is part of a global initiative, Global...